M.G. Alexandrakis

437 total citations
17 papers, 352 citations indexed

About

M.G. Alexandrakis is a scholar working on Hematology, Oncology and Genetics. According to data from OpenAlex, M.G. Alexandrakis has authored 17 papers receiving a total of 352 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Hematology, 6 papers in Oncology and 3 papers in Genetics. Recurrent topics in M.G. Alexandrakis's work include Multiple Myeloma Research and Treatments (6 papers), Acute Myeloid Leukemia Research (3 papers) and Chemokine receptors and signaling (3 papers). M.G. Alexandrakis is often cited by papers focused on Multiple Myeloma Research and Treatments (6 papers), Acute Myeloid Leukemia Research (3 papers) and Chemokine receptors and signaling (3 papers). M.G. Alexandrakis collaborates with scholars based in Greece. M.G. Alexandrakis's co-authors include D. Kyriakou, Freda Passam, Demosthenes Bouros, George Tsirakis, Constantina A. Pappa, Aekaterini Sfiridaki, Emmanuel S. Ganotakis, Despina Kyriakou, Taxiarchis Kourelis and Νikolaos Tzanakis and has published in prestigious journals such as CHEST Journal, Cytokine and Respiratory Medicine.

In The Last Decade

M.G. Alexandrakis

17 papers receiving 342 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M.G. Alexandrakis Greece	11	151	124	88	67	52	17	352
Jolanta Goździk Poland	12	100 0.7×	97 0.8×	57 0.6×	38 0.6×	64 1.2×	62	385
V. Rodriguez United States	8	118 0.8×	162 1.3×	111 1.3×	42 0.6×	37 0.7×	18	395
Hiroko Otsubo Japan	6	188 1.2×	156 1.3×	70 0.8×	46 0.7×	34 0.7×	22	366
Éric Hermet France	12	240 1.6×	214 1.7×	88 1.0×	84 1.3×	93 1.8×	31	548
Uğur Şahin Türkiye	10	125 0.8×	149 1.2×	74 0.8×	23 0.3×	64 1.2×	48	369
Robert C. Blaylock United States	8	160 1.1×	49 0.4×	46 0.5×	34 0.5×	80 1.5×	18	337
C. N. Nair India	14	87 0.6×	120 1.0×	102 1.2×	42 0.6×	34 0.7×	41	493
P. Fixe France	10	163 1.1×	73 0.6×	36 0.4×	41 0.6×	159 3.1×	12	419
G. Fleischhack Germany	11	73 0.5×	113 0.9×	73 0.8×	69 1.0×	10 0.2×	18	396
Kathleen M. Grima United States	12	176 1.2×	45 0.4×	43 0.5×	69 1.0×	100 1.9×	16	448

Countries citing papers authored by M.G. Alexandrakis

Since Specialization

Citations

This map shows the geographic impact of M.G. Alexandrakis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.G. Alexandrakis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.G. Alexandrakis more than expected).

Fields of papers citing papers by M.G. Alexandrakis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.G. Alexandrakis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.G. Alexandrakis. The network helps show where M.G. Alexandrakis may publish in the future.

Co-authorship network of co-authors of M.G. Alexandrakis

This figure shows the co-authorship network connecting the top 25 collaborators of M.G. Alexandrakis. A scholar is included among the top collaborators of M.G. Alexandrakis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.G. Alexandrakis. M.G. Alexandrakis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Pappa, Constantina A., George Tsirakis, Peggy Kanellou, et al.. (2011). Monitoring serum levels ELR+ CXC chemokines and the relationship between microvessel density and angiogenic growth factors in multiple myeloma. Cytokine. 56(3). 616–620. 16 indexed citations

Pappa, Constantina A., Spiros Miyakis, George Tsirakis, et al.. (2007). Serum levels of Interleukin-15 and Interleukin-10 and their correlation with proliferating cell nuclear antigen in multiple myeloma. Cytokine. 37(2). 171–175. 30 indexed citations

Alexandrakis, M.G., et al.. (2006). Seeking prescribing patterns in rural Crete: a pharmacoepidemiological study from a primary care area. Rural and Remote Health. 6(1). 488–488. 12 indexed citations

Passam, Freda, et al.. (2004). Levels of soluble forms of ICAM and VCAM in patients with myelodysplastic syndromes and their prognostic significance. Clinical & Laboratory Haematology. 26(6). 391–395. 6 indexed citations

Stefanidou, Maria, et al.. (2004). Cutaneous alternariosis revealing acute myeloid leukaemia in an adult patient. Mycoses. 47(5-6). 227–230. 10 indexed citations

Alexandrakis, M.G., Freda Passam, Aekaterini Sfiridaki, et al.. (2004). Serum Levels of Leptin in Multiple Myeloma Patients and Its Relation to Angiogenic and Inflammatory Cytokines. The International Journal of Biological Markers. 19(1). 52–57. 25 indexed citations

Alexandrakis, M.G., Freda Passam, Aekaterini Sfiridaki, et al.. (2004). Serum levels of leptin in multiple myeloma patients and its relation to angiogenic and inflammatory cytokines. The International Journal of Biological Markers. 19(1). 52–57. 23 indexed citations

Krasagakis, K., et al.. (2003). Langerhans’ cell histiocytosis and haemophagocytic lymphohistiocytosis in an elderly patient. Journal of the European Academy of Dermatology and Venereology. 17(6). 702–705. 3 indexed citations

Alexandrakis, M.G., et al.. (2002). Urinary N‐telopeptide levels in multiple myeloma patients, correlation with Tc‐99m‐sestaMIBI scintigraphy and other biochemical markers of disease activity. Hematological Oncology. 21(1). 17–24. 8 indexed citations

10.

Alexandrakis, M.G., Freda Passam, Kostas Perisinakis, et al.. (2002). Serum proinflammatory cytokines and its relationship to clinical parameters in lung cancer patients with reactive thrombocytosis. Respiratory Medicine. 96(8). 553–558. 38 indexed citations

11.

Xirouchaki, Nektaria, Νikolaos Tzanakis, Demosthenes Bouros, et al.. (2002). Diagnostic Value of Interleukin-1α, Interleukin-6, and Tumor Necrosis Factor in Pleural Effusions. CHEST Journal. 121(3). 815–820. 56 indexed citations

12.

Kyriakou, D., et al.. (2001). Activated peripheral blood and endothelial cells in thalassemia patients. Annals of Hematology. 80(10). 577–583. 53 indexed citations

13.

Alexandrakis, M.G., et al.. (2001). Value of Tc-99m sestamibi scintigraphy in the detection of bone lesions in multiple myeloma: comparison with Tc-99m methylene diphosphonate. Annals of Hematology. 80(6). 349–353. 26 indexed citations

14.

Alexandrakis, M.G., Stavroula A. Coulocheri, Demosthenes Bouros, Ioannis G. Vlachonikolis, & George D. Eliopoulos. (2000). Significance of Alpha-2-Macroglobulin, Alpha-1-Acid Glycoprotein, and C-Reactive Protein in Pleural Effusion Differentiation. Respiration. 67(1). 30–35. 20 indexed citations

15.

Alexandrakis, M.G., et al.. (1998). Elevated serum TNF-alpha concentrations are predictive of shortened survival in patients with high-risk myelodysplastic syndromes.. PubMed. 29(1). 13–24. 22 indexed citations

16.

Kyriakou, D., et al.. (1996). Increased expression of c-myc p67 oncoprotein in patients with myelodysplastic syndromes in transformation to acute leukaemia.. PubMed. 28(1). 1–7. 3 indexed citations

17.

Kyriakou, D., et al.. (1996). Primary thyroid non-Hodgkin's lymphomas: clinicopathological observations on patients living in the island of Crete.. PubMed. 27(3). 129–33. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact